Back to search
FDAFDA · Food and drugs·Recall number D-809-2013

Mitosol (mitomycin for solution), 0.2 mg/vial, Kit for Ophthalmic Use (NDC 49771-002-01), 3 kits per box (NDC 49771-002-03), Rx only, Manufactured for: Mobius Therapeutics, LLC, 4041 Forest Park Avenue, St. Louis, MO 63108 USA.

Published July 31, 2013 · Recall initiated: January 3, 2013

Summary

FDA records drug Class I recall D-809-2013, published July 31, 2013 and initiated January 3, 2013. Recalling firm: Mobius Therapeutics LLC; Status: Terminated; Reported quantity: 83 boxes; Lot: Lot #: M086920 and M098260, Exp. 08/2013. Class I means a reasonable probability of serious adverse health consequences or death.

Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.

What's the hazard

Non-Sterility: one or more components of the kit have been found to be contaminated with yeast.

What to do

Voluntary: Firm initiated · Telephone

Get an email if MITOSOL has another recall

Free. We only write when there's a new recall that matches. Unsubscribe in one click.

Recall details

Brand
MITOSOL
Manufacturer
Mobius Therapeutics LLC
Distributor
Nationwide and Military and Government Consignees
Lot
Lot #: M086920 and M098260, Exp. 08/2013
Risk classification
Class I
Area (FDA)
drug
Country
United States

Related recalls

Questions about this recall

Was Mitosol (mitomycin for solution), 0.2 mg/vial, Kit for Ophthalmic Use (NDC 49771-002-01), 3 kits per box (NDC 49771-002-03), Rx only, Manufactured for: Mobius Therapeutics, LLC, 4041 Forest Park Avenue, St. Louis, MO 63108 USA. recalled?

Yes. FDA published recall D-809-2013 on July 31, 2013. Reported hazard: Non-Sterility: one or more components of the kit have been found to be contaminated with yeast.

What should I do if I have this product?

Voluntary: Firm initiated · Telephone

How do I know if my unit is part of the recall?

Compare your product details with the notice. Brand: MITOSOL.